First Quadrant’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-32,700
Closed -$954K – 544
2021
Q4
$954K Hold
32,700
– – 0.1% 171
2021
Q3
$705K Hold
32,700
– – 0.08% 208
2021
Q2
$839K Sell
32,700
-2,369
-7% -$50.6K 0.1% 190
2021
Q1
$639K Buy
35,069
+33,278
+1,858% +$553K 0.07% 224
2020
Q4
$21K Buy
+1,791
New +$16.4K ﹤0.01% 521

Other funds holding CDMO

First Quadrant's CDMO Position: Q1 2022 in Review

First Quadrant sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 32,700 shares — an estimated $954K sold.

First Quadrant first reported a position in CDMO in Q4 2020 and held it in 5 quarters. The position peaked at $954K in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • First Quadrant reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 32,700 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $954K.
  • First Quadrant first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • First Quadrant's Avid Bioservices, Inc. Common Stock position peaked at $954K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.